ALLMedicine™ Hepatitis E Center

Mar 24th, 2023 - Coinfection with hepatitis viruses A to E is frequent in persons living with HIV (PLWH) and causes significant morbidity and mortality. Oro-fecal transmissible hepatitis A and E mostly produce acute self-limited episodes in poor income regions and...

Mar 14th, 2023 - Infectious diseases are a major threat to public health, causing serious medical consumption and casualties. Accurate prediction of infectious diseases incidence is of great significance for public health organizations to prevent the spread of dis...

Mar 7th, 2023 - Special attention has been paid to Hepatitis E (HE) prophylaxis for pregnant women due to poor prognosis of HE in this population. We conducted a post-hoc analysis based on the randomized, double-blind, HE vaccine (Hecolin)-controlled phase 3 clin...

Mar 3rd, 2023 - Hepatitis E virus (HEV), the causative agent of hepatitis E, is a common but self-limiting disease. However, in immunosuppressed kidney transplant 47 recipients (KTRs), HEV infection can become chronic. We investigated risk factors associated with...

Feb 23rd, 2023 - Chronic hepatitis B is a global public health problem, with nearly 700,000 deaths each year because of hepatitis B-related diseases. Recent studies have found that some patients who have used nucleot(s)ide analogues(NAs) for some period can achiev...

Feb 23rd, 2023 - Chronic hepatitis B is a global public health problem, with nearly 700,000 deaths each year because of hepatitis B-related diseases. Recent studies have found that some patients who have used nucleot(s)ide analogues(NAs) for some period can achiev...

Jan 31st, 2023 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...

Oct 13th, 2022 - Anemic patients from Mulago Hospital Complex who require fresh whole blood transfusion and with any of the following conditions will be considered for recruitment: cancer, general medical or surgical, obstetric hemorrhage, and/or sickle cell. Elig...

Jun 13th, 2022 - Cecolin is the first Chinese domestic human papillomavirus (HPV) vaccine. Cecolin is designed to protect against HPV types 16 and 18, the most common virus types that lead to cervical cancer. Hecolin is the first prophylactic vaccine against hepat...

Mar 29th, 2022 - Human leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Due to its frequent inapparent course or mild severity with unspecific symptoms and limited availability of diagnostic laboratories the incidence of leptospirosi...

Nov 28th, 2022 - Hepatitis B virus (HBV), which can lead to acute and chronic hepatitis, infects more than 2 billion people worldwide, according to serological evidence. Although vaccines and treatments are available, there are approximately 1.

Jul 21st, 2022 - Two women from Florida pleaded guilty in connection to a conspiracy to falsify data for clinical trials evaluating therapies for irritable bowel syndrome (IBS), among other conditions, the Department of Justice announced. Doctors Without Borders a...

Aug 17th, 2020 - Patients with rheumatoid arthritis treated with baricitinib (Olumiant) were at increased risk for infection in a dose-dependent manner, a review of data from eight double-blind randomized trials and one long-term extension study found. The inciden...

Hepatitis A, B, C, D and what? You're probably not familiar with this one. Visit the CDC Disease of the Week to learn more.

Jun 26th, 2018 - Many things can reactivate chronic hepatitis B virus (HBV) infection—withdrawal of antiviral therapy, pregnancy, and chemotherapy, to name a few. So when a patient with stable chronic HBV virus presented with significant hepatitis flare, clinician.